EUVIMEDEUVIMED entdecken
Crossref

Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS- and DSS-induced colitis in mice

Huifang Xiong, Guohui Xue, Yuting Zhang, Shuang Wu, Qiaoyun Zhao, Rulin Zhao, Nanjin Zhou, Yong Xie

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2022.109645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Huifang Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Digestive disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Ga…. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Projects of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) have a complex pathogenesis that is yet to be completely understood. However, a strong correlation between Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling and IBD has been observed. T-cell immunoglobulin and mucin domain-containing-3 (Tim-3) has been reported to regulate TLR4/NF-κB by interacting with Galectin-9 (Gal-9), and recombinant Gal-9 can activate Tim-3; however, its potential properties in IBD and the underlying mechanism remain unclear. This study aimed to determine how Gal-9 affects experimental colitis in mice. Dextran sodium sulfate (DSS) and 2,4,6-trinitrobenzene sulfonic acid (TNBS) were used to establish colitis in mice, and the severity of the illness was assessed based on body weight, colon length, and histology. Therefore, we explored the effects of Gal-9 treatment on colitis. Furthermore, we analyzed the effect of Gal-9 on the expression of Tim-3 and TLR4/NF-κB pathway in colonic tissues and the serum levels of interferon-gamma (IFN-γ), interleukin (IL)-1β, and IL-6. Tim-3 expression in the colon was notably decreased in mice with TNBS-induced colitis, whereas TLR4/NF-kB expression was significantly increased. Intraperitoneal injection of Gal-9 dramatically decreased the disease activity index and attenuated the level of intestinal mucosal inflammation in TNBS-induced colitis mice (p < 0.05). Intraperitoneal administration of Gal-9 significantly increased Tim-3 expression in the colon and decreased the serum concentrations of IFN-γ, IL-1β, and IL-6. Additionally, Gal-9 treatment significantly downregulated the expression of TLR4 signaling pathway-related proteins. In contrast, Gal-9 did not reduce the severity of DSS-induced colitis. In summary, exogenous Gal-9 increased Tim-3 expression, inhibited the TLR4/NF-κB pathway, and alleviated TNBS-induced colitis in mice but not DSS-induced colitis in mice, revealing its potential therapeutic ramifications for IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisInflammatory Bowel DiseasesMiceAnimalsNF-kappa BToll-Like Receptor 4Interleukin-6Hepatitis A Virus Cellular Receptor 2Trinitrobenzenesulfonic AcidLigandsGalectinsDextran SulfateDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

ColitisGalectin-9Inflammatory bowel diseaseT cell immunoglobulin domain and mucin domain-3Toll-like receptor 4

Substanzen

NF-kappa BToll-Like Receptor 4Interleukin-6Hepatitis A Virus Cellular Receptor 2Trinitrobenzenesulfonic AcidLigandsGalectinsDextran Sulfate

Autor:innen und Institutionen

  • Department of Gastroenterology, Digestive disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Gastroenterology Institute of Jiangxi Province, Nanchang, Jiangxi Provin…
  • Department of Clinical Laboratory, Jiujiang NO.1 People's Hospital, Jiujiang, Jiangxi 332000, China.
  • Jiangxi Provincial Academy of Medical Science, Nanchang, Jiangxi 330006, China.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Projects of Fujian Province

Zitieren

APA

Xiong, H., Xue, G., Zhang, Y., Wu, S., Zhao, Q., Zhao, R., Zhou, N., & Xie, Y. (2023). Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS- and DSS-induced colitis in mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2022.109645

Vancouver

Xiong H, Xue G, Zhang Y, Wu S, Zhao Q, Zhao R, et al. Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS- and DSS-induced colitis in mice. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2022.109645

BibTeX
@article{Xiong2023,
  author = {Xiong, Huifang and Xue, Guohui and Zhang, Yuting and Wu, Shuang and Zhao, Qiaoyun and Zhao, Rulin and Zhou, Nanjin and Xie, Yong},
  title = {Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS- and DSS-induced colitis in mice},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2022.109645}
}
Kostenlos starten →